COGT

← Markets

COGTCogent Biosciences, Inc.

Discussion

Nothing said here yet.

to join the conversation.

—

Thu, Aug 13
8:55 AMYahooCogent Biosciences (COGT) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now
Wed, Jul 15
9:01 AMYahooCogent Bioscience (COGT) Files New Drug Application For Bezuclastinib
Tue, Jun 30
7:00 AMYahooCogent Biosciences Announces Submission of New Drug Application (NDA) for Bezuclastinib in Advanced Systemic Mastocytosis (AdvSM)
Mon, Jun 22
9:14 AMYahooIs Cogent Biosciences (COGT) ’s New Cancer Drug 100 Times More Precise Than What’s Already on the Market?
Fri, Jun 12
7:58 AMYahooCogent Biosciences' Potential Rare Blood Disease Treatment Meets Endpoints in Clinical Trial
7:01 AMYahooCogent Biosciences Announces Preclinical Data from Novel JAK2 V617F Inhibitor at the 2026 European Hematology Association (EHA) Congress
7:00 AMYahooCogent Biosciences Announces Detailed Data from APEX Pivotal Trial of Bezuclastinib in Patients with Advanced Systemic Mastocytosis at the 2026 European Hematology Association (EHA) Congress
Tue, Jun 9
9:13 PMYahooHow Investors May Respond To Cogent Biosciences (COGT) Priority Review For Bezuclastinib GIST Regimen
Sun, Jun 7
11:42 AMYahooIs Cogent Biosciences, Inc. (COGT) A Good Stock To Buy Now?
Sat, May 30
7:00 AMYahooCogent Biosciences Announces Detailed Clinical Data from PEAK Phase 3 Trial with Bezuclastinib in Combination with Sunitinib in Gastrointestinal Stromal Tumors (GIST) at 2026 American Society of Clinical Oncology (ASCO) Annual Meeting
Thu, May 28
7:00 AMYahooCogent Biosciences Announces FDA Acceptance of New Drug Application (NDA) with Priority Review for Bezuclastinib in Combination with Sunitinib for Patients with GIST
Mon, May 25
7:18 PMYahooAssessing Cogent Biosciences (COGT) Valuation After A Strong Year And Recent Share Price Pullback